Cargando…

Sorafenib for Recurrent Hepatocellular Carcinoma after Liver Transplantation

Detalles Bibliográficos
Autores principales:	Kim, Bo Hyun, Park, Joong-Won
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Korean Academy of Medical Sciences 2018
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6209768/ https://www.ncbi.nlm.nih.gov/pubmed/30402051 http://dx.doi.org/10.3346/jkms.2018.33.e286

Ejemplares similares

Can hepatocellular carcinoma recurrence be prevented after liver transplantation?
por: Kim, Jong Man
Publicado: (2021)

Successful Sequential Therapy Involving Regorafenib after Failure of Sorafenib in a Patient with Recurrent Hepatocellular Carcinoma after Liver Transplantation
por: Lee, Soon Kyu, et al.
Publicado: (2020)

Absence of antitumor effects of metformin in sorafenib-treated patients with hepatocellular carcinoma recurrence after hepatic resection and liver transplantation
por: Chung, Yong-Kyu, et al.
Publicado: (2018)

Efficacy of Sorafenib for the Treatment of Post-Transplant Hepatocellular Carcinoma Recurrence
por: Kang, Seong Hee, et al.
Publicado: (2018)

Efficacy and safety of transarterial chemoembolization plus sorafenib in patients with recurrent hepatocellular carcinoma after liver transplantation
por: Zhang, Xia, et al.
Publicado: (2023)

Stem Cell Markers Predict the Response to Sorafenib in Patients with Hepatocellular Carcinoma
por: Kim, Bo Hyun, et al.
Publicado: (2019)

The role of sorafenib in downsizing hepatocellular carcinoma prior to liver transplantation and in treating tumor recurrence
por: Sinakos, Emmanouil, et al.
Publicado: (2011)

Surveillance for hepatocellular carcinoma: It is time to move forward
por: Kim, Bo Hyun, et al.
Publicado: (2022)

Orthotopic liver transplantation after the combined use of locoregional therapy and sorafenib for advanced hepatocellular carcinoma
por: Yoo, Eun Jin, et al.
Publicado: (2013)

Combining Sorafenib and Immunosuppression in Liver Transplant Recipients with Hepatocellular Carcinoma
por: Hussaarts, Koen G. A. M., et al.
Publicado: (2021)

Optimal sequence of systemic therapy after sorafenib failure in patients with hepatocellular carcinoma
por: Han, Sojung, et al.
Publicado: (2020)

The emerging age-pattern changes of patients with hepatocellular carcinoma in Korea
por: Cho, Yuri, et al.
Publicado: (2023)

Liver Resection after Downstaging Hepatocellular Carcinoma with Sorafenib
por: Barbier, L., et al.
Publicado: (2011)

Neo-Adjuvant Use of Sorafenib for Hepatocellular Carcinoma Awaiting Liver Transplantation
por: Minoux, Kate, et al.
Publicado: (2022)

Can metronomic chemotherapy be an alternative to sorafenib in advanced hepatocellular carcinoma?
por: Kim, Do Young
Publicado: (2017)

Sarcopenia as a predictor of post-transplant tumor recurrence after living donor liver transplantation for hepatocellular carcinoma beyond the Milan criteria
por: Kim, Young Ri, et al.
Publicado: (2018)

Sorafenib plus transarterial chemoembolization for unresectable hepatocellular carcinoma
por: Tsilimigras, Diamantis I., et al.
Publicado: (2020)

Hepatocellular recurrence after orthotopic liver transplantation: Is combination of α-fetoprotein and glypican-3 a reliable marker?: Hepatocellular recurrence after orthotopic liver trasplantation
por: Hashemi, Mohammad, et al.
Publicado: (2011)

Risk factors for poor survival after recurrence of hepatocellular carcinoma after liver transplantation
por: Kim, Minjeong, et al.
Publicado: (2021)

Clinical Features and Surveillance of Very Late Hepatocellular Carcinoma Recurrence After Liver Transplantation
por: Alshahrani, Abdulwahab A., et al.
Publicado: (2018)

Antiplatelet Drugs on the Recurrence of Hepatocellular Carcinoma after Liver Transplantation
por: Choi, Mun Chae, et al.
Publicado: (2022)

Impact of Statins on Hepatocellular Carcinoma Recurrence After Living-Donor Liver Transplantation
por: Lee, Okjoo, et al.
Publicado: (2022)

Late Recurrence of Hepatocellular Carcinoma after Liver Transplantation
por: Chok, Kenneth S. H., et al.
Publicado: (2011)

Management of Hepatocellular Carcinoma Recurrence after Liver Transplantation
por: Pelizzaro, Filippo, et al.
Publicado: (2021)

Imaging of hepatocellular carcinoma recurrence after liver transplantation
por: Mamone, Giuseppe, et al.
Publicado: (2023)

Use of Adjuvant Sorafenib in Liver Transplant Recipients with High-Risk Hepatocellular Carcinoma
por: Shetty, Kirti, et al.
Publicado: (2014)

Comparison of Models for Tumor Recurrence after Liver Transplantation for the Patients with Hepatocellular Carcinoma: A Multicenter Long-Term Follow-Up Study
por: Chang, Young, et al.
Publicado: (2019)

Efficacy and safety of lenvatinib in patients with recurrent hepatocellular carcinoma after liver transplantation
por: Bang, Kyunghye, et al.
Publicado: (2022)

Nivolumab for Advanced Hepatocellular Carcinoma with Multiple Lung Metastases after Sorafenib Failure
por: Kim, Jaewoong, et al.
Publicado: (2020)

Ischemic-Free Liver Transplantation Reduces the Recurrence of Hepatocellular Carcinoma After Liver Transplantation
por: Tang, Yunhua, et al.
Publicado: (2021)

Prediction of early recurrence and response to adjuvant Sorafenib for hepatocellular carcinoma after resection
por: Zheng, Liming, et al.
Publicado: (2021)

Preventive strategy for nonalcoholic fatty liver disease-related hepatocellular carcinoma
por: Cho, Yuri, et al.
Publicado: (2023)

A prospective clinical trial on sorafenib treatment of hepatocellular carcinoma before liver transplantation
por: Eilard, Malin Sternby, et al.
Publicado: (2019)

Liver transplantation for intermediate hepatocellular carcinoma: An adaptive approach
por: Biolato, Marco, et al.
Publicado: (2017)

Salvage Liver Transplantation for Recurrent Hepatocellular Carcinoma within UCSF Criteria after Liver Resection
por: Liu, Fei, et al.
Publicado: (2012)

Impact of immunosuppressant therapy on early recurrence of hepatocellular carcinoma after liver transplantation
por: Lee, Ju-Yeun, et al.
Publicado: (2014)

A Novel atTAK Against Hepatocellular Carcinoma: Overcoming Resistance to Sorafenib
por: Pietrobono, Silvia, et al.
Publicado: (2021)

Tumor Response to Transcatheter Arterial Chemoembolization in Recurrent Hepatocellular Carcinoma after Living Donor Liver Transplantation
por: Ko, Heung-Kyu, et al.
Publicado: (2007)

Diffuse Recurrence of Hepatocellular Carcinoma After Liver Resection: Transarterial Chemoembolization (TACE) Combined With Sorafenib Versus TACE Monotherapy
por: Yao, Wang, et al.
Publicado: (2020)

Survival Estimates after Stopping Sorafenib in Patients with Hepatocellular Carcinoma: NEXT Score Development and Validation
por: Lee, Hye Won, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_6r30v12hef4v51ab5l7ml67qlq